Vitrolife Dirección

Dirección controles de criterios 2/4

El CEO de Vitrolife's es Bronwyn Brophy O´Connor , nombrado en Aug 2023, tiene una permanencia de menos de un año. compensación anual total es SEK7.44M, compuesta por 74.5% salario y 25.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.014% de las acciones de la empresa, por valor de SEK3.15M. La antigüedad media del equipo directivo y de la junta directiva es de 1 años y 6.3 años, respectivamente.

Información clave

Bronwyn Brophy O´Connor

Chief Executive Officer (CEO)

kr7.4m

Compensación total

Porcentaje del salario del CEO	74.5%
Permanencia del CEO	less than a year
Participación del CEO	0.01%
Permanencia media de la dirección	1yrs
Promedio de permanencia en la Junta Directiva	6.3yrs

Actualizaciones recientes de la dirección

Recent updates

Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

Apr 03

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Mar 07

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Feb 05

An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Aug 25

Vitrolife (STO:VITR) Could Easily Take On More Debt

Aug 03

Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

May 26

Is Vitrolife (STO:VITR) A Risky Investment?

Jan 23

Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Oct 18

Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Sep 09

Is Vitrolife (STO:VITR) A Risky Investment?

Jul 07

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

May 26

Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Mar 31

Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Feb 07

There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings

Apr 29

Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 16

Who Has Been Selling Vitrolife AB (publ) (STO:VITR) Shares?

Jan 22

Vitrolife (STO:VITR) Shareholders Have Enjoyed An Impressive 289% Share Price Gain

Dec 18

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Bronwyn Brophy O´Connor en comparación con los beneficios de Vitrolife?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-kr4b
Dec 31 2023	kr7m	kr6m	-kr4b

Compensación vs. Mercado: La compensación total ($USD683.29K) de Bronwyn está en línea con el promedio de empresas de tamaño similar en el mercado Swedish ($USD790.88K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Bronwyn con los resultados de la empresa.

CEO

Bronwyn Brophy O´Connor (49 yo)

less than a year

Permanencia

kr7,439,000

Compensación

Ms. Bronwyn Brophy O´Connor is President and Chief Executive Officer at Vitrolife AB (publ) since joining from August 01, 2023. She has an impressive track record as a leader of global Life science and Med...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Bronwyn Brophy O´Connor	CEO & President	less than a year	kr7.44m	0.014% SEK 3.2m
Patrik Tolf	Chief Financial Officer	2.3yrs	sin datos	0.0096% SEK 2.2m
Claus Bisgaard	Senior Vice President of Technologies	no data	sin datos	0.00028% SEK 62.8k
Guillermo Ferrando	Vice President Strategy & Corporate development	1.3yrs	sin datos	sin datos
Olivia Natens	Senior Vice President of Sales & Marketing	less than a year	sin datos	sin datos
Frank Pettersson	Acting Senior Vice President of HR & Sustainability	no data	sin datos	0.0013% SEK 293.7k
Rickard Ericsson	Senior Vice President of Consumables	less than a year	sin datos	0.0061% SEK 1.4m
Ricardo Capella	Senior Vice President Genetic Services	2.3yrs	sin datos	0.0044% SEK 993.3k

1.0yrs

Permanencia media

52.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de VITR no se considera experimentado ( 1 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Henrik Blomquist	Director	5yrs	kr883.00k	sin datos
Jon Sigurdsson	Chairman of the Board	9.3yrs	kr1.25m	0.022% SEK 5.0m
Lars Holmqvist	Independent Director	6.3yrs	kr450.00k	sin datos
Pia Marions	Independent Director	11.1yrs	kr500.00k	0.0037% SEK 827.3k
Karen Soerensen	Independent Director	3.9yrs	kr500.00k	sin datos

6.3yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de VITR se considera experimentada (6.3 años de antigüedad promedio).

Vitrolife Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Vitrolife AB (publ) Announces Election Committee Appointments

Vitrolife AB (publ) Announces Resignation of Maria Forss as Senior Vice President

Insufficient new directors

Vitrolife AB Announces Board Changes

Chief Financial Officer recently bought kr335k worth of stock

Chief Financial Officer recently bought kr535k worth of stock

Recent updates

Vitrolife AB (Publ) Approves Dividend for the Financial Year 2023

Upcoming dividend of kr1.00 per share

First quarter 2024 earnings released: EPS: kr0.85 (vs kr0.74 in 1Q 2023)

Now 22% undervalued

Dividend increased to kr1.00

Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Full year 2023 earnings: EPS misses analyst expectations

Vitrolife AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Vitrolife AB (Publ) Reports Non-Cash Impairment for the Fourth Quarter of 2023

Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Investor sentiment improves as stock rises 21%

Price target decreased by 8.9% to kr257

Third quarter 2023 earnings released: EPS: kr0.90 (vs kr0.80 in 3Q 2022)

Vitrolife AB (publ) Announces Election Committee Appointments

An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Vitrolife AB (publ) Announces Resignation of Maria Forss as Senior Vice President

Insufficient new directors

Vitrolife (STO:VITR) Could Easily Take On More Debt

Vitrolife AB Announces Board Changes

Chief Financial Officer recently bought kr335k worth of stock

Consensus EPS estimates fall by 16%

Price target decreased by 7.4% to kr292

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 15%

Vitrolife AB (publ) to Report Q3, 2024 Results on Oct 24, 2024

Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

Chief Financial Officer recently bought kr535k worth of stock

Chief Financial Officer recently bought kr535k worth of stock

Upcoming dividend of kr0.85 per share at 0.4% yield

Full year 2022 earnings: EPS misses analyst expectations

Full year 2022 earnings released: EPS: kr2.91 (vs kr2.98 in FY 2021)

Vitrolife AB (publ) Proposes Dividend for 2022

Vitrolife AB (publ) Announces Executive Changes

Is Vitrolife (STO:VITR) A Risky Investment?

Price target decreased to kr260

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Vitrolife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

Investor sentiment improved over the past week

Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Vitrolife AB (publ) Announces Election Committee Appointments

Price target decreased to kr307

Now 30% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Vitrolife AB (Publ) Announces Retirement of Thomas Axelsson as CEO

Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Vitrolife AB (publ), Annual General Meeting, Apr 27, 2023

Is Vitrolife (STO:VITR) A Risky Investment?

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Chief Financial Officer recently bought kr496k worth of stock

Consensus forecasts updated

First quarter 2022 earnings: EPS misses analyst expectations

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to kr448

Upcoming dividend of kr0.80 per share

Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Vitrolife AB (Publ) Proposes Dividend

Consensus forecasts updated

Price target decreased to kr498

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitrolife AB (Publ) Proposes Dividend

Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Third quarter 2021 earnings released: EPS kr0.89 (vs kr0.81 in 3Q 2020)

Consensus forecasts updated